Home | Welcome to Contract Pharma   
Last Updated Wednesday, April 23 2014
Print RSS Feed

Breaking News

Related Searches:
March 2, 2010
Walcott named vp quality and compliance  Read More »
March 2, 2010
PPD enters European market with Athlone site  Read More »
March 2, 2010
New appointments as Cytovance expands in international markets  Read More »
March 2, 2010
Asterand adds to PhaseZERO suite of preclinical services  Read More »
March 2, 2010
WuXi and J&JPRD have established a preclinical services and training agreement  Read More »
March 1, 2010
Astellas Pharma has made an unsolicited bid of $3.5 billion in cash to buy all outstanding shares of OSI Pharma.  Read More »
March 1, 2010
AstraZeneca will exercise its option to buy out Merck's interest in AZ's non-PPI products for $647 million.  Read More »
March 1, 2010
Merck KgA has made an offer of $7.2 billion, including assumption of $1.2 billion in debt, to acquire Millipore  Read More »
February 26, 2010
iBio, Inc. has agreed to license its iBioLaunch technology platform and provide technology transfer services to G-Con, LLC for the development and manufacture of plant-expressed influenza vaccines at a new facility in Bryan, TX.  Read More »
February 26, 2010
Regulus Therapeutics has entered into a new collaboration with GlaxoSmithKline to develop and commercialize microRNA therapeutics targeting microRNA-122 in Hepatitis C Viral infection (HCV).  Read More »
February 26, 2010
Peck to succeed Ringo as SVP, worldwide business development, strategy and innovation  Read More »
February 26, 2010
New service takes clients to India to scout CRO and CMO providers  Read More »
February 25, 2010
Pfizer received approval from the FDA for Prevnar 13, a 13-valent pneumococcal conjugate vaccine.  Read More »
February 25, 2010
Genentech’s Phase III study of Avastin (bevacizumab) plus chemotherapy, followed by maintenance use of Avastin alone, increased progression-free survival (PFS) in women with previously untreated advanced ovarian cancer, compared to chemotherapy alon  Read More »
February 25, 2010
In the quarter, income from operations was up 12% to $29.6 million and for the year was $116.3 million (+17%).  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On